Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease
- 1 June 2017
- journal article
- research article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 49 (6) , 604-617
Abstract
No abstract availableKeywords
This publication has 148 references indexed in Scilit:
- Infliximab, Azathioprine, or Combination Therapy for Crohn's DiseaseNew England Journal of Medicine, 2010
- Oral Beclomethasone Dipropionate as an Alternative to Systemic Steroids in Mild to Moderate Ulcerative Colitis Not Responding to AminosalicylatesDigestive Diseases and Sciences, 2009
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2005
- Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurineGastroenterology Clinics of North America, 2004
- Systematic review: the effectiveness of budesonide therapy for Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2002
- Oral budesonide as maintenance therapy in Crohn’s disease—results of a 12‐month studyAlimentary Pharmacology & Therapeutics, 1998
- Colonoscopy of acute colitisDigestive Diseases and Sciences, 1994
- A Placebo-Controlled, Double-Blind, Randomized Trial of Cyclosporine Therapy in Active Chronic Crohn's DiseaseNew England Journal of Medicine, 1989
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987
- Treatment of Crohn's Disease with 6-MercaptopurineNew England Journal of Medicine, 1980